Meanwhile, BRD4 silencing protects against Ang II-induced cardiac hypertrophy via the upregulation of Nrf2-HO-1 and downregulation of TLR4-NF-κB signaling pathways. Here, TLR4 is linked to cardiac hypertrophy.